You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Medical Care

Global PDE Inhibitors Market Analysis 2016-2020 and Forecast 2021-2026

Snapshot

The global PDE Inhibitors market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of PDE Inhibitors by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
PDE5
PDE4
Viagra
Cialis
Levitra
Others

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Hanmi Science Holding
Boehringer Ingelheim
Takeda Pharmaceuticals
Pfizer
Omeros
Anacor Pharmaceuticals
Otsuka
Chiesi Farmaceutici
Verona Pharma
NuSirt Biopharma

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Genitourinary
Cardiovascular Diseases
Neurological Diseases
Dermatological Disorders
Respiratory Diseases
Other Indications

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Table of Contents
Table of Contents
1 Industry Overview
1.1 PDE Inhibitors Industry
Figure PDE Inhibitors Industry Chain Structure
1.1.1 Overview
1.1.2 Development of PDE Inhibitors
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of PDE Inhibitors
1.2.2 Downstream
Table Application Segment of PDE Inhibitors
Table Global PDE Inhibitors Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 PDE Inhibitors Market by Type
3.1 By Type
3.1.1 PDE5
Table Major Company List of PDE5
3.1.2 PDE4
Table Major Company List of PDE4
3.1.3 Viagra
Table Major Company List of Viagra
3.1.4 Cialis
Table Major Company List of Cialis
3.1.5 Levitra
Table Major Company List of Levitra
3.1.6 Others
Table Major Company List of Others
3.2 Market Size
Table Global PDE Inhibitors Market 2016-2020, by Type, in USD Million
Figure Global PDE Inhibitors Market Growth 2016-2020, by Type, in USD Million
Table Global PDE Inhibitors Market 2016-2020, by Type, in Volume
Figure Global PDE Inhibitors Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global PDE Inhibitors Market Forecast 2021-2026, by Type, in USD Million
Table Global PDE Inhibitors Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Hanmi Science Holding (Company Profile, Sales Data etc.)
4.1.1 Hanmi Science Holding Profile
Table Hanmi Science Holding Overview List
4.1.2 Hanmi Science Holding Products & Services
4.1.3 Hanmi Science Holding Business Operation Conditions
Table Business Operation of Hanmi Science Holding (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Boehringer Ingelheim (Company Profile, Sales Data etc.)
4.2.1 Boehringer Ingelheim Profile
Table Boehringer Ingelheim Overview List
4.2.2 Boehringer Ingelheim Products & Services
4.2.3 Boehringer Ingelheim Business Operation Conditions
Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Takeda Pharmaceuticals (Company Profile, Sales Data etc.)
4.3.1 Takeda Pharmaceuticals Profile
Table Takeda Pharmaceuticals Overview List
4.3.2 Takeda Pharmaceuticals Products & Services
4.3.3 Takeda Pharmaceuticals Business Operation Conditions
Table Business Operation of Takeda Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Pfizer (Company Profile, Sales Data etc.)
4.4.1 Pfizer Profile
Table Pfizer Overview List
4.4.2 Pfizer Products & Services
4.4.3 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Omeros (Company Profile, Sales Data etc.)
4.5.1 Omeros Profile
Table Omeros Overview List
4.5.2 Omeros Products & Services
4.5.3 Omeros Business Operation Conditions
Table Business Operation of Omeros (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Anacor Pharmaceuticals (Company Profile, Sales Data etc.)
4.6.1 Anacor Pharmaceuticals Profile
Table Anacor Pharmaceuticals Overview List
4.6.2 Anacor Pharmaceuticals Products & Services
4.6.3 Anacor Pharmaceuticals Business Operation Conditions
Table Business Operation of Anacor Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Otsuka (Company Profile, Sales Data etc.)
4.7.1 Otsuka Profile
Table Otsuka Overview List
4.7.2 Otsuka Products & Services
4.7.3 Otsuka Business Operation Conditions
Table Business Operation of Otsuka (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Chiesi Farmaceutici (Company Profile, Sales Data etc.)
4.8.1 Chiesi Farmaceutici Profile
Table Chiesi Farmaceutici Overview List
4.8.2 Chiesi Farmaceutici Products & Services
4.8.3 Chiesi Farmaceutici Business Operation Conditions
Table Business Operation of Chiesi Farmaceutici (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Verona Pharma (Company Profile, Sales Data etc.)
4.9.1 Verona Pharma Profile
Table Verona Pharma Overview List
4.9.2 Verona Pharma Products & Services
4.9.3 Verona Pharma Business Operation Conditions
Table Business Operation of Verona Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 NuSirt Biopharma (Company Profile, Sales Data etc.)
4.10.1 NuSirt Biopharma Profile
Table NuSirt Biopharma Overview List
4.10.2 NuSirt Biopharma Products & Services
4.10.3 NuSirt Biopharma Business Operation Conditions
Table Business Operation of NuSirt Biopharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global PDE Inhibitors Sales Revenue 2016-2020, by Company, in USD Million
Table Global PDE Inhibitors Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global PDE Inhibitors Sales Revenue Share in 2020, by Company, in USD Million
Table Global PDE Inhibitors Sales Volume 2016-2020, by Company, in Volume
Table Global PDE Inhibitors Sales Volume Share 2016-2020, by Company, in Volume
Figure Global PDE Inhibitors Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America PDE Inhibitors Market Concentration, in 2020
Figure Europe PDE Inhibitors Market Market Concentration, in 2020
Figure Asia-Pacific PDE Inhibitors MMarket Concentration, in 2020
Figure South America PDE Inhibitors Market Concentration, in 2020
Figure Middle East & Africa PDE Inhibitors Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Genitourinary
Figure PDE Inhibitors Demand in Genitourinary, 2016-2020, in USD Million
Figure PDE Inhibitors Demand in Genitourinary, 2016-2020, in Volume
6.1.2 Demand in Cardiovascular Diseases
Figure PDE Inhibitors Demand in Cardiovascular Diseases, 2016-2020, in USD Million
Figure PDE Inhibitors Demand in Cardiovascular Diseases, 2016-2020, in Volume
6.1.3 Demand in Neurological Diseases
Figure PDE Inhibitors Demand in Neurological Diseases, 2016-2020, in USD Million
Figure PDE Inhibitors Demand in Neurological Diseases, 2016-2020, in Volume
6.1.4 Demand in Dermatological Disorders
Figure PDE Inhibitors Demand in Dermatological Disorders, 2016-2020, in USD Million
Figure PDE Inhibitors Demand in Dermatological Disorders, 2016-2020, in Volume
6.1.5 Demand in Respiratory Diseases
Figure PDE Inhibitors Demand in Respiratory Diseases, 2016-2020, in USD Million
Figure PDE Inhibitors Demand in Respiratory Diseases, 2016-2020, in Volume
6.1.6 Demand in Other Indications
Figure PDE Inhibitors Demand in Other Indications, 2016-2020, in USD Million
Figure PDE Inhibitors Demand in Other Indications, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table PDE Inhibitors Demand Forecast 2021-2026, by Application, in USD Million
Figure PDE Inhibitors Market Growth 2021-2026, by Application, in USD Million
Figure PDE Inhibitors Market Share in 2026, by Application, in USD Million
Table PDE Inhibitors Demand Forecast 2021-2026, by Application, in Volume
Table PDE Inhibitors Market Growth 2021-2026, by Application, in Volume
Table PDE Inhibitors Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table PDE Inhibitors Production 2016-2020, by Region, in USD Million
Table PDE Inhibitors Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global PDE Inhibitors Market 2016-2020, by Region, in USD Million
Table Global PDE Inhibitors Market Share 2016-2020, by Region, in USD Million
Table Global PDE Inhibitors Market 2016-2020, by Region, in Volume
Table Global PDE Inhibitors Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America PDE Inhibitors Market Size and Growth 2016-2020, in USD Million
Figure North America PDE Inhibitors Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America PDE Inhibitors Market Size 2016-2020, by Country, in USD Million
Table North America PDE Inhibitors Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe PDE Inhibitors Market Size and Growth 2016-2020, in USD Million
Figure Europe PDE Inhibitors Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe PDE Inhibitors Market Size 2016-2020, by Country, in USD Million
Table Europe PDE Inhibitors Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific PDE Inhibitors Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific PDE Inhibitors Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific PDE Inhibitors Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific PDE Inhibitors Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America PDE Inhibitors Market Size and Growth 2016-2020, in USD Million
Figure South America PDE Inhibitors Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America PDE Inhibitors Market Size 2016-2020, by Country, in USD Million
Table South America PDE Inhibitors Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa PDE Inhibitors Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa PDE Inhibitors Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa PDE Inhibitors Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa PDE Inhibitors Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table PDE Inhibitors Market Forecast 2021-2026, by Region, in USD Million
Table PDE Inhibitors Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
  • FORMAT: PDF
  • PUBLISHED DATE: Apr, 2021
  • NO OF PAGES: 96